Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela Huttner
Stephan Harbarth

Showing results (31-40 of 501) with videos related to

Pageof 51
Sort By:
Swiss Medical Weekly|August 1, 2015
Development of new antibiotics: taking off finally?Esther Bettiol, Stephan Harbarth
Plos One|August 31, 2021
Risk factors for treatment failure in women with uncomplicated lower urinary tract infectionRomain Martischang, Maciek Godycki-Ćwirko, Anna Kowalczyk, et al.
The Journal of Antimicrobial Chemotherapy|March 13, 2019
The pharmacokinetics of nitrofurantoin in healthy female volunteers: a randomized crossover studyAngela Huttner, Rixt A Wijma, Andrew J Stewardson, et al.
Intensive Care Medicine|July 22, 2015
Pros and cons of using biomarkers versus clinical decisions in start and stop decisions for antibiotics in the critical care settingWerner C Albrich, Stephan Harbarth
The Lancet. Public Health|October 16, 2022
Estimating antimicrobial resistance burden in Europe-what are the next steps?Nasreen Hassoun-Kheir, Stephan Harbarth
The Lancet. Infectious Diseases|May 13, 2008
Health-care workers: source, vector, or victim of MRSA?Werner C Albrich, Stephan Harbarth
Plos Medicine|February 21, 2012
Clostridium: transmission difficile?Stephan Harbarth, Matthew H Samore
International Journal of Antimicrobial Agents|August 28, 2007
Prevention of primary bacteraemiaAntoni Juan-Torres, Stephan Harbarth
Emerging Infectious Diseases|June 21, 2005
Antimicrobial resistance determinants and future controlStephan Harbarth, Matthew H Samore
Chest|May 4, 2012
Beads vs bugs?Angela Csaki Huttner, Stephan Harbarth
Pageof 51

Showing results (31-40 of 501) with videos related to

Sort By:
Pageof 51
Swiss Medical Weekly|August 1, 2015
Development of new antibiotics: taking off finally?Esther Bettiol, Stephan Harbarth
Plos One|August 31, 2021
Risk factors for treatment failure in women with uncomplicated lower urinary tract infectionRomain Martischang, Maciek Godycki-Ćwirko, Anna Kowalczyk, et al.
The Journal of Antimicrobial Chemotherapy|March 13, 2019
The pharmacokinetics of nitrofurantoin in healthy female volunteers: a randomized crossover studyAngela Huttner, Rixt A Wijma, Andrew J Stewardson, et al.
Intensive Care Medicine|July 22, 2015
Pros and cons of using biomarkers versus clinical decisions in start and stop decisions for antibiotics in the critical care settingWerner C Albrich, Stephan Harbarth
The Lancet. Public Health|October 16, 2022
Estimating antimicrobial resistance burden in Europe-what are the next steps?Nasreen Hassoun-Kheir, Stephan Harbarth
The Lancet. Infectious Diseases|May 13, 2008
Health-care workers: source, vector, or victim of MRSA?Werner C Albrich, Stephan Harbarth
Plos Medicine|February 21, 2012
Clostridium: transmission difficile?Stephan Harbarth, Matthew H Samore
International Journal of Antimicrobial Agents|August 28, 2007
Prevention of primary bacteraemiaAntoni Juan-Torres, Stephan Harbarth
Emerging Infectious Diseases|June 21, 2005
Antimicrobial resistance determinants and future controlStephan Harbarth, Matthew H Samore
Chest|May 4, 2012
Beads vs bugs?Angela Csaki Huttner, Stephan Harbarth
Pageof 51